Ally Bridge Group (Ny) LLC Tarsus Pharmaceuticals, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 173,144 shares of TARS stock, worth $8.8 Million. This represents 10.88% of its overall portfolio holdings.
Number of Shares
173,144
Previous 321,898
46.21%
Holding current value
$8.8 Million
Previous $10.6 Million
9.45%
% of portfolio
10.88%
Previous 7.52%
Shares
2 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$166 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$165 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$129 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$127 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$115 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.36B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...